Prescription drug · ANDA
Aripiprazole NDC 70518-2736
Aripiprazole 2 mg/1 · Tablet · Oral · REMEDYREPACK INC.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 70518-2736-0 | 70518273600 | 30 TABLET in 1 BLISTER PACK (70518-2736-0)Marketed from May 12, 2020 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Aripiprazole
- Generic name (nonproprietary)
- aripiprazole
- Active ingredients
- Aripiprazole — 2 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- REMEDYREPACK INC.
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 206174
- Marketing start
- Listing expires
- Identifiers
- Product ID 70518-2736_4a8cee22-16db-98ca-e063-6294a90aa648SPL ID 4a8cee22-16db-98ca-e063-6294a90aa648SPL set ID 2bc00231-c2e7-4b9d-93a1-fb796fd8d591RxCUI 602964UNII 82VFR53I78
- Pharmacologic class
- Atypical Antipsychotic
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N470518273600followed by a unit qualifier and the quantityPackage 70518-2736-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
AripiprazoleTabletsare indicated for the treatment of: Schizophrenia IrritabilityAssociatedwith Autistic Disorder TreatmentofTourette’s Disorder Aripiprazole is an atypical antipsychotic. Aripiprazole is indicated for: Schizophrenia ( 14.1 ) Irritability Associated with Autistic Disorder ( 14.4 ) Treatment of Tourette’s Disorder ( 14.5 )
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 206174
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Aripiprazole | Aripiprazole 10 mg/1 | TabletOral | A-S Medication Solutions | 50090-6409 |
| Aripiprazole | Aripiprazole 15 mg/1 | TabletOral | Quallent Pharmaceuticals Health LLC | 82009-091 |
| Aripiprazole | Aripiprazole 5 mg/1 | TabletOral | Unit Dose Solutions, Inc. | 87441-006 |
| Aripiprazole | Aripiprazole 10 mg/1 | TabletOral | Quallent Pharmaceuticals Health LLC | 82009-090 |
| Aripiprazole | Aripiprazole 2 mg/1 | TabletOral | Quallent Pharmaceuticals Health LLC | 82009-088 |
| Aripiprazole | Aripiprazole 5 mg/1 | TabletOral | Quallent Pharmaceuticals Health LLC | 82009-089 |
| Aripiprazole | Aripiprazole 10 mg/1 | TabletOral | Bryant Ranch Prepack | 71335-1515 |
| Aripiprazole | Aripiprazole 5 mg/1 | TabletOral | Bryant Ranch Prepack | 71335-1513 |
| Aripiprazole | Aripiprazole 5 mg/1 | TabletOral | Preferred Pharmaceuticals, Inc. | 68788-7749 |
| Aripiprazole | Aripiprazole 2 mg/1 | TabletOral | Bryant Ranch Prepack | 71335-1682 |
| Aripiprazole | Aripiprazole 2 mg/1 | TabletOral | Coupler LLC | 67046-1638 |
| Aripiprazole | Aripiprazole 15 mg/1 | TabletOral | Ajanta Pharma USA Inc. | 27241-054 |
| Aripiprazole | Aripiprazole 2 mg/1 | TabletOral | Ajanta Pharma USA Inc. | 27241-051 |
| Aripiprazole | Aripiprazole 5 mg/1 | TabletOral | Ajanta Pharma USA Inc. | 27241-052 |
| Aripiprazole | Aripiprazole 10 mg/1 | TabletOral | Ajanta Pharma USA Inc. | 27241-053 |
| Aripiprazole | Aripiprazole 20 mg/1 | TabletOral | Ajanta Pharma USA Inc. | 27241-055 |
| Aripiprazole | Aripiprazole 30 mg/1 | TabletOral | Ajanta Pharma USA Inc. | 27241-056 |